Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes

Summary

This pilot trial seeks to gather preliminary data on the combination of chromium picolinate, the most commonly used form of chromium, and metformin. The trial will recruit type 2 diabetes subjects already on metformin and treat them with chromium for 8 weeks. The results of this trial will provide vital preliminary data including safety and size of effect to direct future studies.

Timeline

Start

2006-01

Primary completion

—

Completion

2007-03

Drugs

Indications